A Successful Treatment of Relapsed Primary CNS Lymphoma Patient with Intraventricular Rituximab Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue

The prognosis for patients with primary central nervous system (CNS) lymphoma (PCNSL) who relapse after the initial response is usually poor. A standard treatment for relapsed PCNSL has not yet been identified because of the heterogeneity of the therapies employed and the lack of large, prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Sung Jin, Kim, Jin Seok, Chang, Jong Hee, Kim, Kyoung Min, Kim, Soo Jeong, Lee, Hye Won, Cheong, June-Won, Lee, Seung Tae, Min, Yoo Hong
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678705/
https://www.ncbi.nlm.nih.gov/pubmed/19430564
http://dx.doi.org/10.3349/ymj.2009.50.2.280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678705/
https://www.ncbi.nlm.nih.gov/pubmed/19430564
http://dx.doi.org/10.3349/ymj.2009.50.2.280

Ejemplares similares